{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:22:40Z","timestamp":1791073360750,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,20]]},"DOI":"10.1097\/qad.0b013e32835b0fa2","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T19:12:09Z","timestamp":1350587529000},"page":"597-605","source":"Crossref","is-referenced-by-count":78,"title":["Declining incidence of AIDS-defining opportunistic illnesses"],"prefix":"10.1097","volume":"27","author":[{"given":"Leilani","family":"Schwarcz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vittinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Schwarcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210130","first-page":"1","article-title":"Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.","volume":"48","author":"Jones","year":"1999","journal-title":"MMWR CDC Surveill Summ"},{"key":"R2-12-20210130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00002","article-title":"Guidelines for preventing opportunistic infections among HIV-infected persons: 2001.","volume":"137","author":"Masur","year":"2002","journal-title":"Ann Internal Med"},{"key":"R3-12-20210130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00126334-200204010-00010","article-title":"Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia.","volume":"29","author":"Dore","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-12-20210130","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/QAD.0b013e32833a3967","article-title":"AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.","volume":"24","author":"Buchacz","year":"2010","journal-title":"AIDS"},{"key":"R5-12-20210130","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-199714000-00010","article-title":"Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.","volume":"11","author":"Brodt","year":"1997","journal-title":"AIDS"},{"key":"R6-12-20210130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/jinf.2001.0810","article-title":"The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.","volume":"42","author":"Ives","year":"2001","journal-title":"J Infect"},{"key":"R7-12-20210130","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","article-title":"AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.","volume":"282","author":"Ledergerber","year":"1999","journal-title":"JAMA"},{"key":"R8-12-20210130","first-page":"1","article-title":"Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.","volume":"58","author":"Mofenson","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"R11-12-20210130","first-page":"43","article-title":"HIVAIDS surveillance report, 1998.","volume":"10","year":"1998","journal-title":"Morb Mortal Wkly Rep"},{"key":"R13-12-20210130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","article-title":"The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.","volume":"317","author":"Fischl","year":"1987","journal-title":"N Engl J Med"},{"key":"R14-12-20210130","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM199309163291202","article-title":"Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.","volume":"329","author":"Nightingale","year":"1993","journal-title":"N Engl J Med"},{"key":"R15-12-20210130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","article-title":"Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.","volume":"297","author":"Hughes","year":"1977","journal-title":"N Engl J Med"},{"key":"R16-12-20210130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-200102160-00008","article-title":"Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis.","volume":"15","author":"Detels","year":"2001","journal-title":"AIDS"},{"key":"R17-12-20210130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.","volume":"337","author":"Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"R18-12-20210130","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMoa012354","article-title":"Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.","volume":"346","author":"Walmsley","year":"2002","journal-title":"N Engl J Med"},{"key":"R19-12-20210130","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200101050-00002","article-title":"ABT-378ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.","volume":"15","author":"Murphy","year":"2001","journal-title":"AIDS"},{"key":"R20-12-20210130","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/09540120600834729","article-title":"AIDS-defining opportunistic illnesses in the HAART era in New York City.","volume":"19","author":"Hanna","year":"2007","journal-title":"AIDS Care"},{"key":"R21-12-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R22-12-20210130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/infdis\/159.3.569","article-title":"The epidemiology of AIDS-related Kaposis sarcoma in San Francisco.","volume":"159","author":"Rutherford","year":"1989","journal-title":"J Infect Dis"},{"key":"R23-12-20210130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/170.1.198","article-title":"Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS.","volume":"170","author":"Katz","year":"1994","journal-title":"J Infect Dis"},{"key":"R24-12-20210130","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(95)91619-9","article-title":"Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposis sarcoma.","volume":"346","author":"Whitby","year":"1995","journal-title":"Lancet"},{"key":"R25-12-20210130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199607253350403","article-title":"Seroconversion to antibodies against Kaposis sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposis sarcoma.","volume":"335","author":"Gao","year":"1996","journal-title":"N Engl J Med"},{"key":"R26-12-20210130","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM199804023381403","article-title":"Sexual transmission and the natural history of human herpesvirus 8 infection.","volume":"338","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"R27-12-20210130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Robins J. marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.","volume":"11","author":"Hernan","year":"2000","journal-title":"Epidemiology"},{"key":"R28-12-20210130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1200\/JCO.2005.04.156","article-title":"Profile of patients with Kaposis sarcoma in the era of highly active antiretroviral therapy.","volume":"23","author":"Gallafent","year":"2005","journal-title":"J Clin Oncol"},{"key":"R29-12-20210130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/603557","article-title":"Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.","volume":"49","author":"dArminio Monforte","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R30-12-20210130","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1572-0241.2005.41949.x","article-title":"Decline in esophageal candidiasis and use of antimycotics in European patients with HIV.","volume":"100","author":"Mocroft","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R31-12-20210130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00001648-199503000-00015","article-title":"Age, gender, and other predictors of the wasting syndrome among HIV-1-infected injecting drug users.","volume":"6","author":"Sorkin","year":"1995","journal-title":"Epidemiology"},{"key":"R32-12-20210130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.21225","article-title":"Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.","volume":"63","author":"Bhaskaran","year":"2008","journal-title":"Ann Neurol"},{"key":"R33-12-20210130","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/01.WNL.0000134665.58343.8D","article-title":"Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort.","volume":"63","author":"Valcour","year":"2004","journal-title":"Neurology"},{"key":"R34-12-20210130","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"R35-12-20210130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.arr.2010.11.002","article-title":"Inflammatory markers in population studies of aging.","volume":"10","author":"Singh","year":"2011","journal-title":"Ageing Res Rev"},{"key":"R37-12-20210130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archinte.165.4.416","article-title":"The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy.","volume":"165","author":"dArminio Monforte","year":"2005","journal-title":"Arch Intern Med"},{"key":"R38-12-20210130","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00002030-199208000-00014","article-title":"The spectrum of HIV-1-related disease among outpatients in New York City.","volume":"6","author":"Greenberg","year":"1992","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201302200-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:17:35Z","timestamp":1618039055000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201302200-00012"}},"subtitle":["results from 16 years of population-based AIDS surveillance"],"short-title":[],"issued":{"date-parts":[[2013,2,20]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32835b0fa2","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,20]]}}}